scPharma

SCPH NASDAQ
5.88
+0.32
+5.76%
Closed 17:00 08/16 EDT
Open
5.64
Prev Close
5.56
High
6.24
Low
5.61
Volume
26.70K
Avg Vol (3M)
77.68K
52 Week High
6.40
52 Week Low
2.440
% Turnover
0.14%
Market Cap
109.26M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers scPharma SCPH stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

scPharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The Company's products administered subcutaneously through the sc2Wear Infusor. The Company’s pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via sc2Wear Infusor for diuresis in heart failure patients outside of the acute care setting. The Company has completed two pivotal clinical studies, four exploratory clinical studies, and 12 human factor studies for Furoscix, and scCeftriaxone an antibiotic used intravenously for the treatment of infections caused by gram-positive and gram-negative organisms.
MORE >

Recently

Name
Price
%Change